Search results

ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.

This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.

In 2023 we’re celebrating the 70th Anniversary since Australia began developing our nation’s Australia’s nuclear capabilities.

ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and produce less waste. 

The release of the Oppenheimer film, the story of the director of the Manhattan Project,  has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.

ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.

Lutetium-177 used for advanced prostate cancer

This week, ANSTO hosted the 10th annual Regional Advisory Safety Committee for research reactors in Asia pacific (RASCAP). This a joint IAEA-Asian Nuclear Safety Network (ANSN) supported forum to foster networking and regional cooperation, and for facilitating use of competencies in the region to cover specific safety issues in research reactors.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.